Stonepine Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
2,662,427
+45,175
+2% +$37K 1.13% 28
2026
Q1
$1.62M Buy
2,617,252
+265,220
+11% +$230K 0.65% 25
2025
Q4
$2.78M Buy
2,352,032
+196,513
+9% +$249K 2.03% 14
2025
Q3
$3.21M Buy
2,155,519
+71,757
+3% +$126K 2.61% 13
2025
Q2
$4.04M Buy
2,083,762
+28,537
+1% +$37.4K 3.97% 8
2025
Q1
$2.51M Sell
2,055,225
-297,874
-13% -$732K 2.44% 16
2024
Q4
$7.11M Buy
2,353,099
+1,243,099
+112% +$3.5M 5.74% 3
2024
Q3
$2.81M Buy
1,110,000
+484,355
+77% +$1.72M 1.77% 20
2024
Q2
$2.94M Sell
625,645
-62,555
-9% -$330K 2.68% 8
2024
Q1
$3.9M Buy
688,200
+370,418
+117% +$2.44M 3.1% 7
2023
Q4
$2.1M Sell
317,782
-174,137
-35% -$1.01M 0.91% 13
2023
Q3
$3.94M Buy
491,919
+9,300
+2% +$86.4K 1.31% 16
2023
Q2
$4.89M Buy
+482,619
New +$4.94M 1.76% 14

Other funds holding TELA

Stonepine Capital Management's TELA Position: Q2 2026 in Review

Stonepine Capital Management increased its TELA Bio (TELA) stake by 1.7% in Q2 2026, buying an estimated $37K and bringing the position to 2,662,427 shares worth $2M. The position accounts for 1.13% of the portfolio, ranked #28.

Stonepine Capital Management first reported a position in TELA in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.11M in Q4 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Stonepine Capital Management held 2,662,427 shares of TELA Bio worth $2M as of Q2 2026.
  • Stonepine Capital Management bought 45,175 TELA Bio shares in Q2 2026, an estimated $37K.
  • TELA Bio made up 1.13% of Stonepine Capital Management's portfolio in Q2 2026, its #28 holding.
  • Stonepine Capital Management first reported a position in TELA Bio in Q2 2023 and has held it in 13 quarters since.
  • Stonepine Capital Management's TELA Bio position peaked at $7.11M in Q4 2024.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.